The CIC-ERF co-deletion underlies fusion independent activation of ETS family member, ETV1, to drive prostate cancer progression
N. Gupta, H. Song, W. Wu, R. Ponce, Y. Lin, J. W. Kim, E. Small, F. Feng, F. W. Huang, R. Okimoto
This study identifies that the co-deletion of CIC and ERF leads to ETV1 activation, driving prostate cancer progression without fusion events.
bioRxiv · Jan 26, 2022Cancer Biology